PB Immune Therapeutics Inc and Seoul National University R&DB Foundation Seek Patent for Antagonistic Anti-CD40 Humanized Antibody

Press/Media: Press / Media

Period2026 Jan 14

Media coverage

1

Media coverage

  • TitlePB Immune Therapeutics Inc and Seoul National University R&DB Foundation Seek Patent for Antagonistic Anti-CD40 Humanized Antibody
    Media name/outletGLOPRM
    Country/TerritoryUnited States
    Date26/1/14
    PersonsGyu-Tae Kim
View all 1
View less